Broker Research

The Company is driving an ambitious global expansion plan with expanding its core areas and diversifying into new businesses.Buy for an upside potential of ~22% from the current level with an investment horizon of 9-12 months.
April 19, 2018, 1:20 p.m.
Publisher: indianotes.com

Mindtree’s 4QFY18 performance was above our/street expectations on both revenue and margin fronts.
April 19, 2018, 10:11 a.m.
Publisher: nirmalbang.com

We have revised ORL’s FY18 EPS upwards by 17.2% and by 17.6% for FY19. Yet severe fluctuations in raw material prices and stressed assets of Indian steel industry would be major irritants. We recommend ’buy’ rating on the stock with target price of Rs 201 (previous target Rs 157) based on 24x FY19e earnings.
April 18, 2018, 1:54 p.m.
Publisher: indianotes.com

Net Sales and PAT of the company are expected to grow at a CAGR of 8% and 6% over 2016 to 2019E respectively.Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.
April 18, 2018, 1:43 p.m.
Publisher: indianotes.com

Net Sales and PAT of the company are expected to grow at a CAGR of 9% and 17% over 2017 to 202GB, respectively. Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.
April 18, 2018, 1:36 p.m.
Publisher: indianotes.com

Domestic formulations have clocked 8.7% growth (ex- bonus) (AIOCD Awacs) for the quarter. We believe that Q4FY18 to be better for the industry and primary sales would show recovery in the domestic space.
April 18, 2018, 10:09 a.m.
Publisher: karvyonline.com

The company’s flagship High Street Phoenix Mall – which commenced operations in 1999 in Mumbai – has increased rental income at a 12% CAGR over FY13-17.
April 18, 2018, 9:58 a.m.
Publisher: motilaloswal.com

Net Sales and PAT of the company are expected to grow at a CAGR of 14% and 9% over 2016 to 2019E, respectively.Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.
April 17, 2018, 2:52 p.m.
Publisher: indianotes.com

Net Sales and PAT of the company are expected to grow at a CAGR of 12% and 14% over 2016 to 2019E, respectively. Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.
April 17, 2018, 2:44 p.m.
Publisher: indianotes.com

Rolling over our valuation to FY20E, we reiterate our BUY recommendation on the stock with a revised Target Price of Rs247 based on 2.4x FY20E Adjusted book value.
April 17, 2018, 2:31 p.m.
Publisher: indianotes.com